


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-0.39%
-0.29%
-0.40%
+0.89%
VKTX
Viking Therapeutics
$36.70
Strengths

Upgraded on attractively valued

Trading below its fair value

Earnings are forecast to grow

Investors confidence is positive
VKTX Price Performance
$36.27 (+1.19%)
$26.28 (+39.65%)
$33.98 (+8.00%)
$39.31 (-6.64%)
VKTX has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

High volatilty

VKTX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Loss widens YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors confidence is positive
Future
Future

Trading below its fair value

Earnings are forecast to grow
![]()
VKTX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
VKTX Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
LLY
1077.47
+0.11%
GPCR
68.88
-1.16%
EBS
12.54
-0.95%
PFE
25.06
+0.04%
NVO
52.42
-0.05%
What is VKTX current stock price?
What are VKTX stock strengths?
What is VKTX Risk Level?
What is VKTX market cap and volume?
What is VKTX current Stock IQ?
Should I buy VKTX stock right now?
Is VKTX a Strong Buy right now?
What does a 'Strong Buy' rating mean for VKTX?
What does a 'Strong Sell' rating mean for VKTX?
What factors influence VKTX's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-0.39%
-0.29%
-0.40%
+0.89%
VKTX
Viking Therapeutics
Current Price
$36.70
Stock Insights
Strengths

Upgraded on attractively valued

Trading below its fair value

Earnings are forecast to grow

Investors confidence is positive
Linked to VKTX
LLY
1077.47
+0.11%
GPCR
68.88
-1.16%
EBS
12.54
-0.95%
PFE
25.06
+0.04%
NVO
52.42
-0.05%

VKTX Price Performance
$36.27 (+1.19%)
$26.28 (+39.65%)
$33.98 (+8.00%)
$39.31 (-6.64%)
VKTX Analysts Opinion
VKTX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Loss widens YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors confidence is positive
Future
Future

Trading below its fair value

Earnings are forecast to grow
![]()
VKTX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
VKTX Street Sentiment is extremely bullish and have positive views on the near-term outlook
VKTX has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

High volatilty

Average key support and resistance price levels
VKTX Stock IQ
VKTX Latest Analysis
Wall Street s Look Optimistic About Viking Therapeutics (VKTX): Should You Buy?. The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So is it worth buying the stock?
Tue Dec 23, 2025
Here is Why H.C. Wainwright Sees Immense Upside for Viking Therapeutics (VKTX). Viking Therapeutics (NASDAQ:VKTX) is one of the most promising mid-cap healthcare stocks under $50. On December 18 H.C. Wainwright analyst Joseph Pantginis reaffirmed his Buy rating on Viking Therapeutics (NASDAQ:VKTX). The analyst has forecasted a huge upside potential of almost 190% from the prevailing range with a price target of $102 a share. Pantginis maintains [….]
Mon Dec 22, 2025
2 Monster Stocks in the Making to Buy and Hold. Key PointsCRISPR Therapeutics and Viking Therapeutics are innovative biotechs with attractive pipelines.
Tue Dec 16, 2025
1 Bold Prediction for Viking Therapeutics in 2026. Key PointsTakeover activity has been high lately in the intensely competitive anti-obesity drug space.
Tue Dec 16, 2025
Viking Therapeutics (VKTX) Deemed Extremely Attractive and Undervalued by Canaccord Cited as Leader in Obesity Clinical Development. Viking Therapeutics Inc. (NASDAQ:VKTX) is one of the stocks that will double in 2026. Earlier on November 12 Canaccord raised the firms price target on Viking Therapeutics to $107 from $106 with a Buy rating on the shares. Canaccord considers Viking Therapeutics shares to be significantly undervalued especially when factoring in the more advanced stage [….]
Tue Dec 16, 2025
This is why Viking Therapeutics Inc. (VKTX) is a Strong Buy on Wall Street. Viking Therapeutics Inc. (NASDAQ:VKTX) is one of the best biotech stocks to buy according to Wall Street analysts. On November 20 H.C. Wainwright reaffirmed its Buy rating and $102 price target on Viking Therapeutics Inc. (NASDAQ:VKTX) after the company finished enrollment ahead of schedule in its Phase 3 VANQUISH-1 obesity study bringing in 4650 adults [….]
Thu Dec 11, 2025
Looking At Viking Therapeuticss Recent Unusual Options Activity. High-rolling investors have positioned themselves ish on Viking Therapeutics (NASDAQ:) and it'.s important for retail traders to take note.\This activity came to our attention today through Benzinga'.s tracking of publicly available options data. The identities of these investors are uncertain but such a significant move in VKTX often signals that someone has privileged information.Today Benzinga'.s options scanner spot
Mon Dec 8, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
VKTX Stock trends
VKTX Stock performance
VKTX Stock analysis
VKTX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.